Headaches, Herbal and Supplement Therapies Flashcards
1
Q
classification of headaches
A
- Do you know why they’re having it or not? If you know why its happening, its secondary!
- If its primary, you don’t know why its happening
- Primary
- No identifiable and treatable underlying cause
- Most common
- Secondary
- Associated with organic causes
- Dental infection or sinusitis
- Brain tumor
- Subarachnoid hemorrhage
- Associated with organic causes
- Tension “common”
- Cluster “severe”
- Migraine “debilitating”
2
Q
Tension vs cluster headaches
A
- Tension
- Mild-moderate, bilateral dull persistent pain
- Location and duration vary
- Treatment usually OTC, usually self-directed
- Avoid medication overuse HA!!!
- Prophylaxis: TCA, stress management therapy
- Cluster
- Severe, unilateral, orbital/temporal pain
- Recurrent (separated by periods of remission)
- Remission may last months to years
- Lacrimation, rhinorrhea, facial flushing, ptosis, miosis
- Treatment: O2 (standard), triptans
- Prophylaxis:
- Verapamil, prednisone
- Difference between the two is bilateral vs unilateral! Cluster is UNILATERAL
3
Q
migraine epidemiology
A
- Typical age of onset 15-35 yo
- Cost of missed workdays: $13 billion per year
- Women of childbearing years are the biggest group associated with migraines
- Migraines are associated with estrogen
4
Q
migraine pathophysiology
A
- Trigger à cortical spreading depression à trigeminal nerve activation à inflammation à nociception à peripheral sensitization
- The pathophys is still not very well understood
5
Q
migraine phases
A
- Prodrome:
- 60% occurrence
- Vague and nonspecific
- Changes in mood, alertness, appetite, food cravings & increased sensory sensitivity
- The trouble is that sometimes its associated with a little confusion – many people have told her that when the prodrome happens, they don’t realize it, their friends and families do.
- Aura
- 20% occurrence
- Progressive neurologic deficits or disturbances with complete recovery
- Visual disturbance, tingling of lips, lower face, and fingers of hand
- May cause motor & speech deficits, most auras resolve in > 1 hour
- Headache
- Severe unilateral pulsating/throbbing pain (bilateral & steady in 1/3 of patients)
- Lasts 4-72 hrs
- Pain worsen with activity, located in temple, forehead, eye, or back of head
- Activates sympathetic nervous system (heightened sensitivity to stimuli)
- Headache resolution
- Spontaneous resolution
- Reverts with sleep or vomiting
- Postdrome
- Rare period of disability, lasting up to 2 days
- Fatigue, anorexia, muscle soreness, poor concentration
6
Q
migraine aggravating factors
A
- Stress
- Emotion
- Glare
- Hypoglycemia, hunger
- Altered sleep pattern
- Menses
- Exercise
- Carbon monoxide
- Excess caffeine use or withdrawal
- Alcohol (red wine)
- Foods with…
- MSG, tyramine
- Nitrites, chocolate
- Aspartame (artificial sweeteners, diet soda)
- Drugs
- Excess analgesic use or withdrawal
- Estrogen
- Cocaine
- Nitroglycerin
7
Q
acute migraine treatment
A
- Goal:
- Relieve the pain and non-headache symptoms
- Allow the patient to resume normal daily activities
- More effective if given early in the course of HA – this is untrue of everything else!!! THIS IS UNIQUE TO MIGRAINE TREATMENT
- Large single dose works better than repetitive small doses
- Oral agents less effective secondary to migraine-induced gastric stasis – poor absorption
-
Non-oral route of administration should be selected for migraines associated with early nausea/vomiting
- If you have a patient that has prodrome or aura, then you can use oral
8
Q
migraine therapies
A
- APAP (Tylenol)
- NSAIDs
- Antiemetics/Dopamine receptor antagonists
- Dexamethasone (reduces recurrence rate) – not fixing the HA today, its to prevent recurrence
- Opiates
- Ergots
- Serotonin agonists (triptans)
9
Q
antiemetics
A
- Prochlorperazine, metoclopramide, chlorpromazine (thorazine) – all are monotherapy as long as they are not given orally – all given with Benadryl for SE
- Oral and non-oral routes available, Inj can be used as monotherapy, oral should not.
- Often given with diphenhydramine to prevent akathisia/dystonic reactions (i.e. Benadryl)
- Management of n/v and delayed gastric emptying
- Metoclopramide increases gastric motility (prokinetic)
- Improves absorption of oral migraine agents
- May have independent anti-migraine action
- ADRs: Sedation, confusion, dyskinetic movements/restlessness
- Primary role is as an adjunct to other acute therapies – especially because oral routes are not very effective
- Treatment of severe migraine in ED (IV)
10
Q
ergot contraindications
A
- Coronary artery disease
- Stroke
- Uncontrolled hypertension
- Peripheral vascular disease
- Ischemic bowel disease
- *Pregnancy (category X)*
- Impaired hepatic or renal function
- Avoid within 24 hrs of 5HT agonist (“triptans”) – but when she admits pts, she asks if they’ve had triptans w/I 3 days
11
Q
ergots place in therapy
A
- IV DHE 45 + IV metoclopramide is an alternative for treatment of intractable severe migraine (>72 hours) in ED
- Raskin protocol*
- IV DHE 45 should not be used as monotherapy
- Ergotamine is not the drug of choice for most patients because of issues of efficacy and side effects
- Place in therapy may be for those with prolonged duration of attacks (>48 hours) and possible frequent headache recurrence
12
Q
choice of triptan
A
- Few head-to-head trials
- Meta-analysis of 53 trials (over 24,000 patients)*
- Concluded that all of the oral drugs are effective and well tolerated
- Highest likelihood of consistent success
- Rizatriptan 10 mg
- Eletriptan 80 mg
- Almotriptan 12.5 mg
- Bottom line – no efficacy data that definitively support use of one triptan vs. another
- For new onset, she always starts with sumatriptan
- If she has a pt with long lasting she will go straight for the frova, etc.
- TRIPTANS ARE NOT PROPHYLACTIC!!! THEY ARE ABORTIVE!!
- Choice should be individualized
- Different pharmacologic properties/delivery routes
- Sumatriptan offers the most options for drug delivery
- Naratriptan has lowest recurrence rates but slowest onset of action
- Naratriptan and frovatriptan have better side effect profile but possible reduced efficacy
- Highest likelihood of consistent success found with rizatriptan, eletriptan, almotriptan
-
Switch to another triptan
- Studies showing patients fail one, respond to another
13
Q
triptans adverse effects
A
- Adverse effects
- Tingling
- Sensation of warmth/flushing
- Weakness/dizziness
- Somnolence/drowsiness
- Numbness
- Malaise
- Unpleasant taste with nasal spray
- Feeling of pressure or heaviness in chest & neck – 20%
- Not accompanied by ECG changes
- Pregnancy Category C
14
Q
triptans contraindications
A
- its vasoconstrictive but not nearly as bad as the ergots
- Coronary artery disease
- Stroke
- Uncontrolled hypertension
- Peripheral vascular disease
- Ischemic bowel disease
- Within 24hrs of therapy of other triptan or ergot – many clinicians say within 72hrs
- Within 2 weeks MAOI
- Except naratriptan, eletriptan, frovatriptan
15
Q
triptans drug interactions
A
- SSRI (citalopram, fluoxetine, sertraline, paroxetine, fluvoxamine), venlafaxine, sibutramine
- “serotonin syndrome”
- CNS irritability, increased muscle tone, shivering, myoclonus, and altered consciousness
- “serotonin syndrome”
- Sumatriptan, rizatriptan, zolmitriptan, almotriptan + MAOI
- Serum concentrations of 5-HT1 agonists may be elevated
- Increases the risk of cardiac toxicity
- Serum concentrations of 5-HT1 agonists may be elevated
- Ergots (DHE 45, ergotamine)
- The risk of vasospastic reactions may be increased
- Do not use within 24 hours
- Triptans + other triptan
- Concomitant use contraindicated
-
Rizatriptan and propranolol
- AUC Rizatriptan 70%
-
Eletriptan metabolized by CYP3A4 – significant drug interactions
- ketoconazole, itraconazole, clarithromycin, ritonavir, nelfinavir – avoid eletriptan within 72 hrs
16
Q
migraine prophylaxis
A
- Indication for use
- Suffer from substantial disability
- HA ≥ 3 days/month
- HA > 2 days/week or 8 days/month
- Severe or long-lasting HA > 12 hours
- Interference with daily activities despite acute treatments
- Abortive medications use > 2 days/week
- Patient preference
- Cost of acute medications problematic – they are pretty pricey
- Patients in whom acute treatments are contraindicated, ineffective, overused, or intolerable
- Suffer from substantial disability
- Principles
- Utilize lowest effective dose – this is different form abortive tx
- Increase dose slowly until improvement is seen or side effects occur
- Give adequate trial (2-3 months)
- If patient has co-existing condition, consider in prophylaxis choice
- Precipitating medications should be avoided
- Therapy should be reevaluated after one year by slowly tapering medication
- Patient compliance is essential
- PATIENTS MUST KEEP HEADACHE DIARY
- Classes of medications
- Beta-blockers (really propranolol)
- Calcium-channel blockers
- Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs)
- Antidepressants
- Dexamethasone (no immediate relief but reduced recurrence up to 72 hours)
- Anticonvulsants*
- 50-75% of patients will have a 50% reduction in frequency of headaches
17
Q
calcitonin gnee-related peptide receptor antagonist
A
- Erenumab-aooe (alimovig) – human monoclonal antibody that antagonizes CGRP receptor function
- 70mg to 140mg subQ monthly ($345 to $1400 per month)
- Trial compared 70mg to 140mg to placebo
- Reduction of migraine days per month from 8.3 by:
- 3.2 days in 70mg group
- 3.7 days in 140mg group
- 1.8 days in placebo group
- ADEs: constipation, injection site reactions, and ?
- Migraine prophylaxis